Src inhibitors in lung cancer: current status and future directions

Clinical Lung Cancer
Sacha I RothschildFaye M Johnson

Abstract

Src tyrosine kinases regulate multiple genetic and signaling pathways involved in the proliferation, survival, angiogenesis, invasion, and migration of various types of cancer cells They are frequently expressed and activated in many cancer types, including lung cancer. Several Src inhibitors, including dasatinib, saracatinib, bosutinib, and KX2-391, are currently being investigated in clinical trials. Preliminary results of the use of single-agent Src inhibitors in unselected patients with lung cancer show that these inhibitors have a favorable safety profile and anticancer activity. Their combination with cytotoxic chemotherapy, other targeted therapy, and radiation therapy is currently being explored. In this review, we summarize the rationale for and the current status of Src inhibitor development and discuss future directions based on emerging preclinical data.

References

Jan 1, 1992·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·N N MazurenkoF L Kisseljov
Jan 1, 1997·Annual Review of Cell and Developmental Biology·S M Thomas, J S Brugge
Dec 15, 2000·Oncogene·R B Irby, T J Yeatman
Jun 27, 2003·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·T MasakiS Kuriyama
Apr 10, 2004·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Mark S DuxburyEdward E Whang
Jun 2, 2004·Nature Reviews. Cancer·Timothy J Yeatman
Oct 19, 2004·Oncogene·Paul A BromannSara A Courtneidge
Oct 6, 2005·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Faye M JohnsonNicholas J Donato
Mar 15, 2006·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Justin M Summy, Gary E Gallick
Mar 14, 2007·Anti-cancer Drugs·Ami N Shah, Gary E Gallick
Apr 6, 2007·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·Eric B Haura
Feb 26, 2009·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·Phillip R PurnellOliver Gautschi
Apr 18, 2009·Molecular Cancer Research : MCR·Teun J de VriesJenneke Klein-Nulend
May 20, 2009·The Journal of Clinical Investigation·Martin L SosRoman K Thomas
Sep 30, 2009·Nature Reviews. Clinical Oncology·Lori C KimEric B Haura
Oct 29, 2009·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Lauren Averett ByersFaye M Johnson
Nov 19, 2009·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Evan Y YuCora N Sternberg
Feb 10, 2010·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Eric B HauraGerold Bepler

❮ Previous
Next ❯

Citations

Jan 10, 2013·PloS One·Mark L GrimesPaul Shannon
Apr 26, 2012·Future Medicinal Chemistry·Francesca MusumeciMaurizio Botta
May 18, 2012·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·Sacha I RothschildOliver Gautschi
May 14, 2011·Lancet·Jan P van MeerbeeckDirk K M De Ruysscher
Aug 17, 2010·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Sacha I RothschildOliver Gautschi
Jul 22, 2011·Journal of Signal Transduction·Banibrata Sen, Faye M Johnson
Mar 31, 2015·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Anguo CuiYangfu Jiang
Jun 6, 2015·Cancer Research and Treatment : Official Journal of Korean Cancer Association·Keun-Yong EomIn Ah Kim
Apr 12, 2015·Journal of Biochemistry·Chitose Oneyama, Masato Okada
Jun 8, 2011·Cancer Biology & Therapy·Xiao-Feng Le, Robert C Bast
Aug 30, 2014·PloS One·Anthony SzedlakCarlo Piermarocchi
Jan 25, 2014·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Minghui CaoXi Chen
May 8, 2018·Cancers·Federica Lo SardoGiovanni Blandino
Jul 3, 2018·Genes to Cells : Devoted to Molecular & Cellular Mechanisms·Rie KokudaChitose Oneyama
Jun 6, 2019·American Journal of Respiratory and Critical Care Medicine·Irati GarmendiaJackeline Agorreta
Mar 3, 2020·Free Radical Research·Le Ba Nam, Young-Sam Keum
May 1, 2019·Journal of Experimental & Clinical Cancer Research : CR·Wen-Chien HuangYongjie Wang
Jun 26, 2018·Oncotarget·Ewa RupniewskaOlivier E Pardo
Aug 20, 2020·Molecular and Cellular Biochemistry·Ting ZhuGuangmao Yu
Jul 5, 2011·Oncotarget·Mark A Eckert, Jing Yang

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Critical Reviews in Oncogenesis
Helen Creedon, Valerie G Brunton
Neoplasia : an International Journal for Oncology Research
Alexey Aleshin, Richard S Finn
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
Erica L Mayer, Ian E Krop
© 2021 Meta ULC. All rights reserved